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Background: The precise etiology of endometriosis is not fully understood; the involvement of stem cells theory is
a new hypothesis. Related studies mainly focus on stemness-related genes, and pluripotency markers may play a
role in the etiology of endometriosis. We aimed to analyze the transcription pluripotency factors sex-determining
region Y-box 2 (SOX2), Nanog homeobox (NANOG), and octamer-binding protein 4 (OCT4) in the endometrium of
reproductive-age women with and without ovarian endometriosis.
Methods: We recruited 26 women with laparoscopy-diagnosed ovarian endometriosis (endometriosis group) and
16 disease-free women (control group) to the study. Endometrial and endometriotic samples were collected. SOX2,
NANOG, and OCT4 expression were analyzed with quantitative real-time polymerase chain reaction, western
blotting, and immunohistochemistry.
Results: Compared to the control group, SOX2 mRNA and protein expression was significantly higher in the
eutopic endometrium of participants in the endometriosis group. In the endometriosis group, SOX2 and NANOG
mRNA and protein expression were significantly increased in ectopic endometrium compared with eutopic
endometrium; there was a trend towards lower OCT4 mRNA expression and higher OCT4 protein expression in
ectopic endometrium.
Conclusions: The transcription pluripotency factors SOX2 and NANOG were overexpression in ovarian
endometriosis, their role in pathogenesis of endometriosis should be further studied.
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Endometriosis is a chronic disease characterized by the
presence of ectopic endometrial implants [1]. Current
treatments such as medication or surgery are effective to
an extent; however, some patients experience infertility,
pain from ineffective treatment, recurrence, and even ma-
lignancy. Thus, identification of the mechanisms under-
lying the pathogenesis of endometriosis will facilitate the
development of more effective treatment for this disorder.
Despite considerable investigation, the precise etiology
and pathogenesis of endometriosis is unknown. To date,
the leading theories are retrograde menstruation, coelomic* Correspondence: weihuang64@163.com
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unless otherwise stated.metaplasia, embryonic cell rest, and lymphovascular
metastasis [2]. However, none of them can annotate the
pathogenesis to a point for all types of endometriosis.
Current research involving stem cells should shed some
light on the puzzling mechanisms of this disease [3-6].
However, data on stem or progenitor cell function in
endometriosis are scarce due to the technical limitations
to stem cell research. Current studies mainly focus on
stemness-related genes; the pluripotency markers sex-
determining region Y-box 2 (SOX2), Nanog homeobox
(NANOG), and octamer-binding protein 4 (OCT4) are
the most often studied [7-9]. SOX2 is a member of the
SOX (SRY-related high mobility group [HMG] box) gene
family that encodes transcription factors with a single
HMG DNA-binding domain [10]. SOX genes bind to the
minor groove in DNA to control diverse developmentaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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differentiation, and proliferation [11]. OCT4 is a member
of the POU domain transcription factor family and plays a
key role in the regulation of self-renewal and pluripotency
in embryonic stem cells and primordial germ cells [12],
while NANOG is a homeobox gene and has essential roles
in maintaining self-renewal and the undifferentiated state
of pluripotent stem cells [13]. In addition to maintaining
the self-renewal ability of stem cells, SOX2, NANOG, and
OCT4 are involved in cancer cell migration and invasion
[13-15]. Aberrant SOX2, NANOG, and OCT4 expression
has been demonstrated in endometriotic tissues, and
OCT4 promoted endometrial cell migration activity [7-9].
However, these markers are not identified exclusively in
women with ovarian endometriosis. Therefore, we aimed
to examine and compare SOX2, NANOG, and OCT4 ex-
pression in endometrial or endometriotic tissues from
women with and without ovarian endometriosis.Methods
Study population
The Medical Research Review Board of West China Second
University Hospital, Sichuan University (Sichuan, China)
approved the study, and written informed consent was ob-
tained from the human participants of the study. The par-
ticipants were reproductive age women and had regular
menstrual cycles. None had received hormonal treatment
within the previous three months. Participants with ade-
nomyosis, leiomyomas, endometrial hyperplasia, genital
tumors, and acute pelvic inflammatory disease were ex-
cluded. From May 2012 to December 2012, we recruited
42 women who had undergone simultaneous laparoscopy
and hysteroscopy to the study. Of these, 26 women with
deep ovarian endometriosis (diameter of cyst is from 3 cm
to 5 cm) were laparoscopically diagnosed and further con-
firmed by pathology (endometriosis group). The r-AFS
score was used for disease stage (17 stage III, and 9 stage
IV). The remaining 16 (age 24–32 years, mean 27 years)
were controls who had undergone simultaneous laparos-
copy and hysteroscopy for infertility which had no visible
evidence of endometriosis or adhesions during surgery
(Table 1).Table 1 Characteristics of study population
Characteristics Endometriosis
group (n = 26)
Non-endometriosis
group (n = 16)
Age (yrs) 27.94 ± 3.45 (22–35) 26.90 ± 2.47 (24–32)
Body mass index (kg/m2) 20.81 ± 2.94 19.14 ± 2.05
Infertility duration (yrs) 3.06 ± 1.71 3.10 ± 1.85
r-AFS staging (n)
Stage III 17 0
Stage IV 9 0Eutopic and ectopic endometrial tissues from ovarian
endometrioma and from normal control endometrium
were obtained during surgery. Of the 16 control speci-
mens, 10 were used for quantitative real-time polymer-
ase chain reaction (PCR) and the remaining six for
western blot and immunohistochemistry analysis. Of the
26 endometriosis specimens, 13 were used for quantita-
tive real-time PCR and the remaining 13 for western
blot and immunohistochemistry analysis. Tissues were
stored in a microfuge tube at −80°C for PCR and west-
ern blot analysis, or immediately fixed in 10% buffered
formalin and paraffin-embedded for immunohistochemi-
cal and hematoxylin and eosin staining. All participants
were determined to be in the proliferative phase of their
menstrual cycle as assessed by the timing of their last
menstrual period and histological dating [16].
RNA isolation, cDNA synthesis, and real-time PCR
Total RNA was extracted using TRIzol according to the
manufacturer’s protocol (Life Technologies Inc., Carlsbad,
CA, USA); the quality and concentration of purified RNA
were analyzed using a NanoVue Plus spectrophotometer
(Health-careBio-ScienceAB, Uppsala, Sweden). The nu-
cleotide to protein ratios (A260:A280) of all samples
were within the acceptable boundaries of 1.8 and 2.1.
First-strand complementary DNA (cDNA) synthesis was
performed with a PrimeScript RT Reagent Kit (TaKaRa
Biotechnology, Dalian, China) used according to the
manufacturer’s protocol at 37°C for 30 min, followed by
deactivation at 85°C for 8 s. PCR was performed using
primers synthesized by Sangon Biotech (Shanghai,
China) (Table 2). cDNA samples were diluted 10-fold
for PCR. Each well of the PCR plate contained 5 μL Eva-
Green Supermix (Bio-Rad Laboratories, Hercules, CA,
USA), 1 μL of each primer (10 μmol/L), and 3 μL diluted
cDNA. Amplification was performed over 39 cycles of 95°C
for 30 s, 95°C for 5 s, and 60°C for 10 s; melting curve
analysis from 65°C to 95°C at a rate of 5 s per step was
performed to determine data quality using a CFX96 Real-
Time PCR Detection System (Bio-Rad Laboratories). Only
data with single melting peaks were included in the final
analysis. All experiments were performed in triplicate.
The threshold cycle values were normalized to the
threshold value of human glyceraldehyde-3-phosphate
dehydrogenase (GADPH) and the results expressed as
the mean ± SD.
Immunohistochemistry
Immunohistochemical staining was performed using
monoclonal mouse anti-human SOX2 (ab75485, Abcam,
Cambridge, MA, USA), polyclonal rabbit anti-human
NANOG (ab80892, Abcam), and rabbit anti-human
Table 2 Primer sequences used in quantitative real-time PCR
Gene Sense primer 5′ –3′ Antisense primer 5′ –3′ Genbank accession NM
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTGATGAG NM_002046
SOX2 TACAGCATGTCCTACTCGCAG GAGGAAGAGGTAACCACAGGG NM_003106
NANOG AAGGTCCCGGTCAAGAAACAG CTTCTGCGTCACACCATTGC NM_024865
OCT4 GCAGCGACTATGCACAACGA CCAGAGTGGTGACGGAGACA NM_002701
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serial sections were prepared, mounted on gelatin-coated
slides, dried overnight at 37°C, deparaffinized in xylene,
and rehydrated through a graded ethanol series. To re-
trieve the epitopes, the slides were immersed in citrate
antigen retrieval buffer (pH 6) for 10 min at 120°C. After
cooling, the sections were incubated with 3% H2O2 for
10 min to block endogenous peroxidase activity, blocked
with 10% normal goat serum for 15–30 min, then incu-
bated with the primary antibodies (1:100 SOX2, 1:400
NANOG, 1:100 OCT4) at 4°C overnight. Secondary bio-
tinylated antibody and streptavidin-peroxidase conjugate
were applied according to the manufacturer’s instructions
(Beijing Zhongshan Biotech, Beijing, China); staining was
visualized with diaminobenzidine, and then the sections
were counterstained with hematoxylin and mounted.
Colorectal carcinoma tissues were used as positive con-
trols. Negative controls were performed by incubatingFigure 1 Quantitative real-time PCR analysis of SOX2, NANOG, and OC
and paired eutopic and ectopic endometrium specimens (n = 13). Double-
Asterisks denote significant differences between eutopic or ectopic endom
differences between eutopic and ectopic endometrium. P < 0.05 was signisections with phosphate-buffered saline instead of pri-
mary antibodies.
Western blot analysis
Total proteins were collected using radioimmunopreci-
pitation lysis buffer (P0013B, Beyotime Biotechnology,
Shanghai, China) according to the manufacturer’s in-
structions. Protein concentration was determined using
a bicinchoninic acid assay kit (Beyotime Biotechnology).
Protein (30 ng) from each specimen underwent 10% so-
dium dodecyl sulfate–polyacrylamide gel electrophoresis
and was transferred to polyvinylidene fluoride membranes
(Millipore, Billerica, MA, USA). The membranes were
blocked for 1 h in 5% defatted milk at room temperature.
Subsequently, the membranes were incubated with mono-
clonal mouse anti-human SOX2 (1:200; ab75485, Abcam),
polyclonal rabbit anti-human NANOG (1:300; ab80892,
Abcam), OCT4 (1:500; ab18976, Abcam), and rabbitT4 mRNA. Analysis was carried out on normal endometrium (n = 10)
asterisk values are significantly different from single-asterisk values.
etrium and normal endometrium. Connecting lines denote significant
ficant. Error bars denote SEM.
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China) antibodies overnight at 4°C. Then, the membranes
were incubated with horseradish peroxidase–conjugated
secondary antibody for 1 h at room temperature. Proteins
were detected with a chemiluminescence kit (Millipore)
and the strength of the bands was analyzed with ImageJ2x
(National Institutes of Health, Bethesda, MD, USA). Pro-
tein levels were normalized to that of the internal control
GAPDH.
Statistical analysis
Statistical analysis was performed using SPSS version 18.0
(SPSS, Chicago, IL, USA). All data are expressed as the
mean ± SD. Differences between groups were evaluatedFigure 2 Western blot analysis of SOX2, NANOG, and OCT protein. (A
endometrium (n = 6) and paired eutopic and ectopic endometrium (n = 13
values. Asterisks denote significant differences between eutopic or ectopic
significant differences between eutopic and ectopic endometrium. P < 0.05
of SOX2, NANOG, and OCT4 protein. GAPDH, Internal control.with one-way analysis of variance with a post hoc test
(Student–Newman–Keuls method); P < 0.05 was consid-
ered statistically significant (two-tailed).
Results
SOX2, NANOG, and OCT4 mRNA expression
SOX2 mRNA expression in the eutopic endometrium of
ovarian endometriosis were significantly higher than that
in normal endometrium (P = 0.02); expression of NANOG
and OCT4 mRNA in eutopic endometrium increased but
no statistically significant when compared with normal
controls. When compared to eutopic endometrium, SOX2
and NANOG mRNA expression in ectopic endometrium
was significantly increased (P = 0.004; P = 0.01, respectively),) Relative levels of SOX2, NANOG, and OCT4 protein in normal
). Double-asterisk values are significantly different from single-asterisk
endometrium and normal endometrium. Connecting lines denote
was significant. Error bars denote SEM. (B) Representative western blot
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tended to be lower (P = 0.05). Both SOX2 and NANOG
mRNA expression in ectopic endometrium were signifi-
cantly higher than that in normal endometrium (P = 0.001;
P = 0.009, respectively), and only OCT4 mRNA expression
in ectopic endometrium tended to be lower (P > 0.05)
(Figure 1).
Expression and location of SOX2, NANOG, and OCT4
protein
Compared to normal endometrium, SOX2 protein expres-
sion in the eutopic and ectopic endometrium of ovarianFigure 3 SOX2, NANOG, and OCT4 immunohistochemical staining. Paraff
specimens (n = 7) were examined. SOX2, NANOG, and OCT4 immunostaining
(D, I, N) and ectopic endometrium (E, J, O) of endometriosis, and positive co
(×400 magnification). Arrows denote positive staining.endometriosis was significantly increased (P= 0.04; P= 0.009,
respectively); NANOG protein expression in ectopic endo-
metrium was statistically significantly different (P = 0.04);
OCT4 protein expression in eutopic and ectopic endo-
metrium tended to be higher (P > 0.05). Both SOX2 and
NANOG protein expression in ectopic endometrium were
significantly higher than that in eutopic endometrium
(P = 0.01; P = 0.007, respectively), while only OCT4
protein expression in ectopic endometrium tended to
be higher (P > 0.05) (Figure 2).
SOX2, NANOG, and OCT4 protein were mainly expressed
in the nuclei of glandular epithelial or stromal cells ofin-embedded normal (n = 6) and paired eutopic and ectopic endometrium
in normal endometrium (C, H, M) of control and in eutopic endometrium
ntrol (A, F, K) and negative control (B, G, L) were revealed, respectively
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and normal control endometrium, with low expression
detected in the cytoplasm of both cell types (Figure 3).
Discussion
SOX2 and OCT4 are transcription factors essential for
maintaining the self-renewal and pluripotent phenotype
of embryonic stem cells [12,17]. Previous studies have
revealed that they are also key factors in the reprogram-
ming of somatic cells to a pluripotent state [18]. Similarly,
NANOG can maintain the pluripotency and self-renewal
characteristics of embryonic stem cells [19]. It has also
been verified that these factors are involved in cancer cell
migration and invasion [13,15,20]. Several other studies
have also demonstrated that they are expressed in human
normal endometrium, endometriotic tissues, and in endo-
metrial cancer [7-9,21].
Emerging evidence suggests that there is decreased
apoptosis, increased proliferation, and higher migration
and invasion ability in the eutopic endometrium of endo-
metriosis [22,23]. The aberrant SOX2 expression in ovar-
ian endometriosis in our study, consistent with that
reported previously [7,8], may indicate a stem cell origin of
endometriosis. As a pluripotent transcription factor, SOX2
overexpression in eutopic and ectopic endometrial speci-
mens of ovarian endometriosis was expected to result in
increased proliferation and inhibit apoptosis by targeting
apoptosis-related proteins as it does in neural stem cells
and prostate cancer [24,25]. As SOX2 affected migration/
invasion by downregulating matrix metalloproteinase-2 in
colorectal cancer [15], we believe that its overexpression in
ovarian endometriosis may be a potential mechanism that
leads to the intrinsic differentiation of eutopic endometrial
cells from that in normal endometria, and play an import-
ant role in the disease pathogenesis.
In this study, NANOG expression was significantly in-
creased in the ectopic endometrium of women with
ovarian endometriosis. This result differs from that of
previous studies [7,9]. The reason may be related to the
study population, the ages of the participants, or their
menstrual cycles.
Endometriosis is usually considered an estrogen-dependent
disorder [1]. In ectopic endometrium, estradiol (E2) is
overproduced by aromatase and is not metabolized be-
cause the ectopic endometrium lacks 17β-hydroxysteroid
dehydrogenase type 2 activity. Two recent studies support
the positive link between high levels of E2 and SOX2 or
NANOG expression [26,27]. SOX2 and NANOG overex-
pression may foster self-renewal and increase cell survival
in ovarian endometrial tissues that can further facilitate
ectopic tissue growth. More importantly, data from large
cohort studies indicate that endometriosis patients have
an increased risk of ovarian cancer [28,29]. Recently, two
studies revealed that SOX2 overexpression and advancedovarian cancer were closely associated [30,31]. Another
study demonstrated that NANOG was involved in ovarian
tumorigenesis through migration and invasion [13]. In this
study, NANOG expression in ectopic endometrium was
nearly six times that in eutopic endometrium, and SOX2
expression was four times in ectopic endometrium. The
results indicate that NANOG alone or in combination
with SOX2 may contribute to the transformation of ovar-
ian endometriosis to ovarian cancer.
In our study, OCT4 expression was similar among nor-
mal endometrium and eutopic and ectopic endometrium
of endometriosis. It has been established that OCT4 is a
key transcription factor in the regulation of self-renewal
and pluripotency in embryonic stem cells and in the re-
programming of somatic cells to a pluripotent state.
Chang et al. found that OCT4 was upregulated in human
ectopic endometriotic tissues and that it contributed to
ectopic endometrial growth by stimulating endometrial
cell migration activity [9]. However, we could not verify
this in the present study, which might have been due to
the study population and the menstrual cycles of the par-
ticipants; therefore, further studies would require a larger
sample size.
In our study, there were some drawback like sample
size is not large and amount of endometrial tissue cannot
match all experimental items that result in some index
not reach statistical significance. Infertile women are
chosen as control is not perfect, however, it’s hard to get
endometrial tissue from normal fertile women that
undergo laparoscopy and hysteroscopy procedure. A
larger sample size and the functional research of SOX2
and NANOG in pathogenesis of endometriosis is antici-
pated in our further study.
Conclusions
In reproductive-age women with ovarian endometriosis,
the transcriptional factor SOX2 and NANOG are over
expression. Future studies is need to determine their role
in pathogenesis of ovarian endometriosis.
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